Cited by 492Abdominal vascular conditions and treatmentsVenous Thromboembolism Diagnosis and ManagementLiver Disease and Transplantation

Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy

Open access
Condat, Bertrand, Pessione, Fabienne, Denninger, Marie Helene, Hillaire, Sophie, Valla, Dominique·2000·Hepatology

Abstract

Characteristics and outcomes of recent portal or mesenteric venous thrombosis are ill-known. We intended to compare these features with those of patients with portal cavernoma, and also to assess the incidence of recanalization of recent thrombosis on anticoagulation therapy. All patients seen between 1983 and 1999 were enrolled into this retrospective study if recent portal or mesenteric venous thrombosis or portal cavernoma had been documented, and if cancer of the liver, pancreas, or bile duct, intrahepatic block including cirrhosis, and obstruction of the hepatic veins had been ruled out. The proportion of recent thrombosis was 7% in patients seen before 1990 and 56% after 1994 (P< .05). Patients with recent thrombosis (n = 33) or cavernoma (n = 108) did not differ with regard to age, sex ratio, or prevalence of prothrombotic states and of previous thrombotic events. In patients with recent thrombosis, septic pylephlebitis was more common and the incidence of gastrointestinal bleeding was lower (2.4 vs. 12.7/100 patient-years). Recanalization occurred in 25 of 27 patients given anticoagulation and 0 of 2 patients not given anticoagulation. The probability of recanalization was related to the extent of thrombosis (P= .003). In conclusion, mesenteric or portal venous thrombosis is increasingly recognized at an early stage. The features differentiating recent thrombosis and cavernoma are related to silent onset precluding early recognition and therapy in the latter. Frequent association with prothrombotic states and frequent recanalization on anticoagulation support the recommendation of early anticoagulation therapy in all patients with recent portal vein thrombosis.

Integrity signals

Registry

Crossref · 10.1053/jhep.2000.16597

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the absence of bowel infarction, anticoagulation with continuous heparin infusion has been shown to cause frequent recanalization with better outcome in MVT.

    “In the absence of bowel infarction, the main stay of treatment is anticoagulation with continuous heparin infusion which has been shown to cause frequent recanalization with better outcome[104].”

    From Ischemic bowel disease in 2021. (2021) · cites this paper as [104]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Condat, B., Pessione, F., Denninger, M. H., Hillaire, S., & Valla, D.
Affiliations
Inserm (FR)
Corresponding author
Valla, Dominique
Venue
Hepatology
Published
2000-09
Volume
32
Issue
3
Pages
466-470
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2053776083
Cited by
492
References
50
Citations by year
2026: 8 · 2025: 7 · 2024: 19 · 2023: 14 · 2022: 19 · 2021: 24 · 2020: 25 · 2019: 19 · 2018: 25 · 2017: 21 · 2016: 20 · 2015: 29 · 2014: 38 · 2013: 25 · 2012: 23
FWCI
8.14
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
portal vein thrombosis, mesenteric vein thrombosis, portal cavernoma, thrombus recanalization, anticoagulation, hypercoagulability, gastrointestinal bleeding, thrombosis incidence
MeSH terms
Adult, Anticoagulants, Female, Hemangioma, Cavernous, Humans, Male, Mesenteric Veins, Middle Aged, Portal Vein, Retrospective Studies, Treatment Outcome, Venous Thrombosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review